Shopping Cart
Remove All
Your shopping cart is currently empty
MG-T-19, a TIM-3 inhibitor (KD=0.26 μM), significantly inhibited the interaction of TIM-3 with PtdSer, CEACAM1, and Gal-9, and increased the production of TNF-α and IFN-γ in PBMCs, which reactivated the tumor-attacking ability of T cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | - | In Stock | |
| 5 mg | $483 | - | In Stock | |
| 10 mg | $692 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,490 | - | In Stock | |
| 100 mg | $1,970 | - | In Stock | |
| 200 mg | $2,690 | - | In Stock |
| Description | MG-T-19, a TIM-3 inhibitor (KD=0.26 μM), significantly inhibited the interaction of TIM-3 with PtdSer, CEACAM1, and Gal-9, and increased the production of TNF-α and IFN-γ in PBMCs, which reactivated the tumor-attacking ability of T cells. |
| In vitro | MG-T-19 is a mannose-derived compound with antimicrobial activity. In vitro, MG-T-19 (2-16 μg/mL) effectively inhibits the growth of various Pseudomonas aeruginosa strains, including drug-resistant clinical isolates. MG-T-19 blocks bacterial adhesion to host cells and prevents biofilm formation across different human cell models[1]. |
| In vivo | In a murine lung infection model, MG-T-19 (10 mg/kg, intranasal administration) significantly reduces bacterial burden in lung tissue, alleviates histopathological damage, and improves survival. MG-T-19 also enhances the efficacy of antibiotics like ceftazidime, showing synergistic antimicrobial effects[1]. |
| Synonyms | MGT-19, MG T19 |
| Molecular Weight | 596.6 |
| Formula | C18H8Br2ClF3N4O2S |
| Cas No. | 328540-44-9 |
| Smiles | O=C(NC1=CC(Cl)=CC=C1O)C2=NN3C(N=C(C=C3C(F)(F)F)C=4SC=C(Br)C4)=C2Br |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.